{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:06:16Z","timestamp":1770498376676,"version":"3.49.0"},"reference-count":56,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":187,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,7,9]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Triple therapy with a proton pump inhibitor, clarithromycin and amoxicillin is widely used for <jats:italic>H. pylori<\/jats:italic> infection. The appropriate length of treatment remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To determine whether length of treatment has an impact on the cost\u2010effectiveness of triple therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The study took the form of a cost\u2010effectiveness analysis spanning 2\u2003years. The perspective was societal and the setting, ambulatory care. Subjects were <jats:italic>Helicobacter pylori<\/jats:italic>\u2010positive patients with a duodenal ulcer. The triple therapy trials spanned 7, 10 or 14\u2003days and the main outcome measures were cost per patient and marginal cost for additional cured patient calculated for a low cost\u2010of\u2010care setting (Spain), for a high\u2010cost setting (USA), and for two follow\u2010up strategies: (i) systematic <jats:sup>13<\/jats:sup>C\u2010urea breath test after eradication; (ii) clinical follow\u2010up, breath\u2010test if symptoms recurred.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Base\u2010case analysis showed that for both the <jats:sup>13<\/jats:sup>C\u2010UBT and the clinical follow\u2010up branches, lowest costs were obtained with 7\u2010day schedules both in Spain and the USA. Sensitivity analysis showed that in Spain, 10\u2010day therapies would have to increase 7\u2010day cure rates by 10\u201312% to become cost\u2010effective. In contrast, in the USA only a 3\u20135% increase was needed. The corresponding figures for 14\u2010day therapy were 25\u201335% and 8\u201311%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Seven\u2010day therapies seem the most cost\u2010effective strategy. However, in high\u2010cost areas the differences were less evident.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.01031.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:44:26Z","timestamp":1047354266000},"page":"1067-1076","source":"Crossref","is-referenced-by-count":36,"title":["What is the optimal length of proton pump inhibitor\u2010based triple therapies for <i>H. pylori<\/i>? A cost\u2010effectiveness analysis"],"prefix":"10.1111","volume":"15","author":[{"given":"X.","family":"Calvet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gen\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"L\u00d3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199701000-00002"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/1998\/170180"},{"key":"e_1_2_6_4_2","first-page":"65","article-title":"Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease","volume":"272","author":"NIH Consensus Conference","year":"1994","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.15.1651"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00602.x"},{"key":"e_1_2_6_7_2","first-page":"299","article-title":"The 1998 national Belgian consensus meeting on HP\u2010related diseases: an extensive summary. The HP Belgian contact group organized in CHU Brugmann, Brussels","volume":"61","author":"Deltenre M","year":"1998","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_6_8_2","first-page":"A84","article-title":"Helicobacter eradication with a one week triple therapy: meta\u2010analysis of French studies","volume":"43","author":"Lamouliatte H","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00405.x"},{"key":"e_1_2_6_10_2","first-page":"81","article-title":"Seven\u2010day therapy with omeprazole, clarithromycin and amoxicillin for treatment of Helicobacter pylori infection","volume":"21","author":"Comet R","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00230.x"},{"key":"e_1_2_6_12_2","first-page":"A80","article-title":"Seven or twelve days triple therapies combining omeprazole with amoxicillin and clarithromycin to cure H. pylori","volume":"112","author":"Burette A","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_13_2","first-page":"A145","article-title":"Triple therapy with omeprazole, clarithromycin and amoxicillin for cure of Helicobacter pylori infection","volume":"39","author":"Chen P","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_14_2","first-page":"A95","article-title":"7 vs. 14 day treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients","volume":"41","author":"Dammann HG","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_15_2","first-page":"A136","article-title":"Randomized comparison of 1 week and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for the cure of Helicobacter pylori infection in gastric and duodenal ulcer patients","volume":"112","author":"Habu Y","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_16_2","first-page":"A94","article-title":"Triple therapy omeprazole (O)\u2003+\u2003amoxicillin (A)\u2003+\u2003clarithromycin (C) for Helicobacter pylori (HP) infection. 6 vs 12 days. Results and cost analysis","volume":"41","author":"Hermida C","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80646-X"},{"key":"e_1_2_6_18_2","first-page":"A144","article-title":"Eradication of H. pylori infection in peptic ulcers with four different drug regimens","volume":"39","author":"Katicic M","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.111282000.x"},{"key":"e_1_2_6_20_2","first-page":"A80","article-title":"Lansoprazole (Lanso) 30\u2003mg or 60\u2003mg combined with two antibiotics (AMOX) and clarithromycin (Clari) to eradicate Helicobacter pylori (H. pylori)","volume":"43","author":"Lamouliatte H","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00343.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00012.x"},{"key":"e_1_2_6_23_2","first-page":"82","article-title":"Erradicaci\u00f3n de Helicobacter pylori con omeprazol, amoxicilina y claritromicina: una vs dos semanas","volume":"89","author":"Mones J","year":"1997","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_6_24_2","first-page":"879","article-title":"Helicobacter pylori, efficacy of the new triple therapy in six and twelve\u2010day schedules","volume":"89","author":"P\u00e9rez Mota A","year":"1997","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_6_25_2","first-page":"A87","article-title":"The combination of omeprazole, amoxicillin and clarithromycin eradicates Helicobacter pylori in 95% of cases\u20147\u2010day equals 10\u2010day therapy","volume":"112","author":"Ching CK","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_26_2","first-page":"149","article-title":"Resultados de la triple terapia omeprazol\u2013claritromicina\u2013amoxicilina durante 10 d\u00edas en la erradicaci\u00f3n de la infecci\u00f3n por Helicobacter pylori","volume":"90","author":"Gancedo P","year":"1998","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00744.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70101-5"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70100-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00004"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7027.349"},{"key":"e_1_2_6_32_2","first-page":"A88","article-title":"Second (re\u2010treatment) H. pylori therapy failure: Should a third eradication regimen be tried?","volume":"43","author":"Gisbert JP","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00779.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00735.x"},{"key":"e_1_2_6_35_2","first-page":"47","article-title":"\u00bfCual debe ser la duraci\u00f3n del tratamiento de la infecci\u00f3n por Helicobacter pylori con omeprazol, claritromicina y amoxicilina?","volume":"23","author":"Gene E","year":"2000","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_6_36_2","first-page":"A81","article-title":"Clinical practice results of quadruple treatment in Helicobacter pylori eradication failure with OCA\u20107","volume":"43","author":"Borda F","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_37_2","first-page":"203","article-title":"Tratamiento de la infecci\u00f3n por Helicobacter pylori","volume":"21","author":"Calvet X.","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_6_38_2","first-page":"A105","article-title":"Short\u2010course treatment to eradicate H. pylori in 246 patients with peptic ulcer disease","volume":"41","author":"Huelin J","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_39_2","first-page":"224","article-title":"[13C]urea breath test to confirm eradication of Helicobacter pylori","volume":"90","author":"Slomianski A","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_40_2","first-page":"1268","article-title":"Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment","volume":"92","author":"Rollan A","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613015"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.68.801.549"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094873"},{"key":"e_1_2_6_44_2","first-page":"1381","article-title":"90% cure: which anti\u2010Helicobacter therapy can achieve this treatment goal?","volume":"90","author":"De Boer WA","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093230"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(06)80110-0"},{"key":"e_1_2_6_47_2","first-page":"12\u2003149","article-title":"per la qual s\u2019aproven els preus p\u00fablics corresponents als serveis que presta l\u2019Institut Catal\u00e0 de la Salut","volume":"2505","author":"Ordre de 27 de Septembre de 1997","year":"1997","journal-title":"Diari Oficial de la Generalitat Catalunya"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00376.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00943.x"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9901900314"},{"key":"e_1_2_6_51_2","first-page":"248","article-title":"Highly effective twice\u2010daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?","volume":"92","author":"Lerang F","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70119-8"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850172485"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)00196-5"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01031.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01031.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:47:04Z","timestamp":1697507224000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01031.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,9]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7,9]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01031.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01031.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,9]]}}}